BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 24113469)

  • 61. Revisiting overdiagnosis and fatality in thyroid cancer.
    Vollmer RT
    Am J Clin Pathol; 2014 Jan; 141(1):128-32. PubMed ID: 24343746
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The prevalence and significance of incidental thyroid nodules identified on computed tomography.
    Yoon DY; Chang SK; Choi CS; Yun EJ; Seo YL; Nam ES; Cho SJ; Rho YS; Ahn HY
    J Comput Assist Tomogr; 2008; 32(5):810-5. PubMed ID: 18830117
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Thyroid cancers incidentally detected at imaging in a 10-year period: how many cancers would be missed with use of the recommendations from the Society of Radiologists in Ultrasound?
    Bahl M; Sosa JA; Nelson RC; Hobbs HA; Wnuk NM; Hoang JK
    Radiology; 2014 Jun; 271(3):888-94. PubMed ID: 24475865
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Descriptive epidemiology of thyroid cancer in France: incidence, mortality and survival.
    Colonna M; Bossard N; Guizard AV; Remontet L; Grosclaude P;
    Ann Endocrinol (Paris); 2010 Mar; 71(2):95-101. PubMed ID: 20036351
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Rates of malignancy in incidentally discovered thyroid nodules evaluated with sonography and fine-needle aspiration.
    Liebeskind A; Sikora AG; Komisar A; Slavit D; Fried K
    J Ultrasound Med; 2005 May; 24(5):629-34. PubMed ID: 15840794
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Time trends for thyroid cancer in northwestern Spain: true rise in the incidence of micro and larger forms of papillary thyroid carcinoma.
    Rego-Iraeta A; Pérez-Méndez LF; Mantinan B; Garcia-Mayor RV
    Thyroid; 2009 Apr; 19(4):333-40. PubMed ID: 19355823
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Thyroid cancer incidence attributable to overdiagnosis in the United States 1981-2011.
    O'Grady TJ; Gates MA; Boscoe FP
    Int J Cancer; 2015 Dec; 137(11):2664-73. PubMed ID: 26069163
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Rising Incidence and Incidence-Based Mortality of Thyroid Cancer in California, 2000-2017.
    Yan KL; Li S; Tseng CH; Kim J; Nguyen DT; Dawood NB; Livhits MJ; Yeh MW; Leung AM
    J Clin Endocrinol Metab; 2020 Jun; 105(6):. PubMed ID: 32166320
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A birth cohort analysis of the incidence of papillary thyroid cancer in the United States, 1973-2004.
    Zhu C; Zheng T; Kilfoy BA; Han X; Ma S; Ba Y; Bai Y; Wang R; Zhu Y; Zhang Y
    Thyroid; 2009 Oct; 19(10):1061-6. PubMed ID: 19732011
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Respective roles of thyroglobulin, radioiodine imaging, and positron emission tomography in the assessment of thyroid cancer.
    Lind P; Kohlfürst S
    Semin Nucl Med; 2006 Jul; 36(3):194-205. PubMed ID: 16762610
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Impact of lymphocytic thyroiditis on incidence of pathological incidental thyroid carcinoma.
    Farrell E; Heffron C; Murphy M; O'Leary G; Sheahan P
    Head Neck; 2017 Jan; 39(1):122-127. PubMed ID: 27792295
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Role of Ultrasound in Predicting Tumor Invasiveness in Follicular Variant of Papillary Thyroid Carcinoma.
    Hahn SY; Shin JH; Oh YL; Kim TH; Lim Y; Choi JS
    Thyroid; 2017 Sep; 27(9):1177-1184. PubMed ID: 28699414
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Radioactive iodine scanning is not beneficial but its use persists for euthyroid patients.
    Panneerselvan R; Schneider DF; Sippel RS; Chen H
    J Surg Res; 2013 Sep; 184(1):269-73. PubMed ID: 23623585
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Pediatric thyroid cancer: An update from the SEER database 2007-2012.
    Dermody S; Walls A; Harley EH
    Int J Pediatr Otorhinolaryngol; 2016 Oct; 89():121-6. PubMed ID: 27619041
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Thyroid Ultrasound and the Increase in Diagnosis of Low-Risk Thyroid Cancer.
    Haymart MR; Banerjee M; Reyes-Gastelum D; Caoili E; Norton EC
    J Clin Endocrinol Metab; 2019 Mar; 104(3):785-792. PubMed ID: 30329071
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Thyroid Nodule Size at Ultrasound as a Predictor of Malignancy and Final Pathologic Size.
    Cavallo A; Johnson DN; White MG; Siddiqui S; Antic T; Mathew M; Grogan RH; Angelos P; Kaplan EL; Cipriani NA
    Thyroid; 2017 May; 27(5):641-650. PubMed ID: 28052718
    [TBL] [Abstract][Full Text] [Related]  

  • 77.
    Pattison DA; Bozin M; Gorelik A; Hofman MS; Hicks RJ; Skandarajah A
    J Nucl Med; 2018 May; 59(5):749-755. PubMed ID: 29025986
    [No Abstract]   [Full Text] [Related]  

  • 78. Analysis of the rising incidence of thyroid cancer using the Surveillance, Epidemiology and End Results national cancer data registry.
    Cramer JD; Fu P; Harth KC; Margevicius S; Wilhelm SM
    Surgery; 2010 Dec; 148(6):1147-52; discussion 1152-3. PubMed ID: 21134545
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Central echogenic areas in thyroid nodules: Diagnostic performance in prediction of papillary cancer.
    Siebert SM; Jeffrey RB; Gomez AJ; Kamaya A
    Eur J Radiol; 2018 Apr; 101():45-49. PubMed ID: 29571800
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Evaluation of thyroid incidentaloma.
    Wilhelm S
    Surg Clin North Am; 2014 Jun; 94(3):485-97. PubMed ID: 24857572
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.